About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Epstein - Barr Virus Associated Hemophagocytic Syndrome

compare naloxone and naltrexone

naloxone vs naltrexone
Basnayake BMDB1, Kannangara T1, Athauda BMSB2, Welagedara WMRL1, Hemachandra KHDT1
Department of 1Medicine and 2Hematology, Teaching Hospital Kandy, Sri Lanka.
Corresponding Author:
Dr. BMBD Basnayake
Email: bmdbbasnayake@yahoo.com
Received: 11-JAN-2016 Accepted: 28-MAR-2016 Published Online: 15-MAY-2016
DOI: http://dx.doi.org/10.17659/01.2016.0052
Abstract
Hemophagocytic syndrome is a rare disorder with impaired activity of natural killer cells and cytotoxic T lymphocytes. There is excessive activation of lymphocytes and macrophages, hypercytokinaemia and uncontrolled hemophagocytosis. It is characterized by fever, pancytopenia, splenomegaly and hemophagocytosis in bone marrow and other tissues. The syndrome is associated with collagen vascular diseases, malignancies and infections most frequently caused by viruses, prominently linked with Epstein-Barr viral infection. We report a case of Epstein-Barr virus associated hemophagocytic syndrome in a 19 year old boy who responded to treatment with steroids and etoposide.
Keywords : Epstein-Barr Virus Infections, Etoposide, Hemophagocytic Lymphohistocytosis, Macrophages, Pancytopenia.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share